14 employees
EpiDisease provides biomedical solutions, epigenetic diagnostic tools, and characterization of new epigenetic drugs.
2014
$344K
from 1 investors over 1 rounds
Epidisease SL raised $344K on July 26, 2018
Investors: Fundación Botín